Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
5.41M
-
Shares change
-
+92.9K
-
Total reported value, excl. options
-
$17.9M
-
Value change
-
+$304K
-
Put/Call ratio
-
0
-
Number of buys
-
24
-
Number of sells
-
-15
-
Price
-
$3.30
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q3 2025
75 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q3 2025.
Anixa Biosciences Inc - Common Stock (ANIX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.41M shares
of 37.9M outstanding shares and own 14.3% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.42M shares), D.A. DAVIDSON & CO. (614K shares), Laird Norton Wetherby Trust Company, LLC (597K shares), UBS Group AG (474K shares), MISSION WEALTH MANAGEMENT, LP (356K shares), GEODE CAPITAL MANAGEMENT, LLC (344K shares), BANK OF AMERICA CORP /DE/ (214K shares), BlackRock, Inc. (161K shares), STATE STREET CORP (121K shares), and CITADEL ADVISORS LLC (96K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.